Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › EphA3 directed CAR-T cells for treatment of tumors

EphA3 directed CAR-T cells for treatment of tumors

US Patent 12139544 · Granted Nov 12, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and materials for treating cancer2025
Methods and materials for treating cancer2025
A19-144, A2-73 and certain anticholinesterase inhibitor compositions and method 2023
Method of increasing the efficacy of CAR-T immunotherapy using lenzilumab2023
Method of increasing the efficacy of CAR-T immunotherapy using lenzilumab2023
Treatment of cancer using a CD123 chimeric antigen receptor2023
Methods of treating CART-T cell therapy-induced neuroinflammation using a GM-CSF2021
Methods of treating CART-T cell therapy-induced neuroinflammation using a GM-CSF2021
Method of reducing tumor relapse rate in immunotherapy by administration of lenz2021
Method of reducing tumor relapse rate in immunotherapy by administration of lenz2021
Method of reducing the level of non-GM-CSF cytokines/chemokines in immunotherapy2021
Method of reducing the level of non-GM-CSF cytokines/chemokines in immunotherapy2021